Applied DNA Reports Fiscal Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Applied DNA Sciences (APDN) PT Lowered to $3 at Maxim Group
August 15, 2018 8:19 AM EDTMaxim Group analyst Anthony Vendetti lowered the price target on Applied DNA Sciences (NASDAQ: APDN) to $3.00 (from $5.00) while maintaining a Buy rating.
... MoreApplied DNA Sciences (APDN) Misses Q3 EPS by 5c, Revenues Miss
August 13, 2018 4:09 PM EDTApplied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.10), $0.05 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1 million versus the consensus estimate of $2.75 million.
Revenues decreased 43% for the third quarter of fiscal 2018 to $1.0 million, compared with $1.8 million reported in the third quarter of fiscal 2017, and remained flat as compared to revenues for the fiscal second quarter ended March 31, 2018. The year-over-year decrease in revenues is primarily attributable to shipments... More